Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Glucotrack (GCTK) Gains from Investment Securities (2016 - 2018)

Historic Gains from Investment Securities for Glucotrack (GCTK) over the last 5 years, with Q4 2018 value amounting to $399892.0.

  • Glucotrack's Gains from Investment Securities fell 6616.17% to $399892.0 in Q4 2018 from the same period last year, while for Dec 2018 it was $148102.0, marking a year-over-year decrease of 8368.99%. This contributed to the annual value of -$1000.0 for FY2022, which is 9761.9% up from last year.
  • Latest data reveals that Glucotrack reported Gains from Investment Securities of $399892.0 as of Q4 2018, which was down 6616.17% from -$91762.0 recorded in Q3 2018.
  • Glucotrack's 5-year Gains from Investment Securities high stood at $1.2 million for Q4 2017, and its period low was -$6.1 million during Q2 2014.
  • Its 5-year average for Gains from Investment Securities is -$324766.8, with a median of -$71858.5 in 2015.
  • Per our database at Business Quant, Glucotrack's Gains from Investment Securities surged by 109685.58% in 2016 and then crashed by 14201.94% in 2017.
  • Glucotrack's Gains from Investment Securities (Quarter) stood at -$50635.0 in 2014, then surged by 45.02% to -$27839.0 in 2015, then surged by 1014.5% to $254587.0 in 2016, then soared by 364.19% to $1.2 million in 2017, then crashed by 66.16% to $399892.0 in 2018.
  • Its Gains from Investment Securities stands at $399892.0 for Q4 2018, versus -$91762.0 for Q3 2018 and -$82081.0 for Q2 2018.